dw a 2114r has been researched along with Cystadenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Furuhashi, Y; Iwata, M; Kano, T; Kawai, M; Kikkawa, F; Maeda, O; Misawa, T; Morikawa, Y; Oguchi, H; Tomada, Y | 1 |
| Hamaguchi, K; Kato, T; Kishi, N; Matsumura, T; Miyahara, K; Nishimura, H; Tashiro, M; Yakushiji, M | 1 |
2 other study(ies) available for dw a 2114r and Cystadenocarcinoma
| Article | Year |
|---|---|
Accumulation of cis-diamminedichloroplatinum (II) and its analogues in sensitive and resistant human ovarian carcinoma cells.
Topics: Antineoplastic Agents; Carboplatin; Cisplatin; Cystadenocarcinoma; Female; Humans; Ovarian Neoplasms; Sensitivity and Specificity; Tumor Cells, Cultured | 1992 |
Antitumor activity of cisplatin analogs against malignant ovarian tumor xenografts into nude mice.
Topics: Animals; Antineoplastic Agents; Carboplatin; Cell Line; Cisplatin; Cystadenocarcinoma; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Organoplatinum Compounds; Ovarian Neoplasms | 1988 |